Texas Permanent School Fund’s Ironwood Pharmaceuticals IRWD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-120,245
Closed -$1.05M 692
2024
Q1
$1.05M Buy
120,245
+1,557
+1% +$18.9K 0.01% 1305
2023
Q4
$1.36M Buy
118,688
+2,076
+2% +$20.5K 0.01% 1210
2023
Q3
$1.12M Sell
116,612
-2,386
-2% -$23.4K 0.01% 1203
2023
Q2
$1.27M Sell
118,998
-683
-0.6% -$7.34K 0.01% 1177
2023
Q1
$1.26M Buy
119,681
+29,962
+33% +$336K 0.01% 1165
2022
Q4
$1.11M Sell
89,719
-6,157
-6% -$69.8K 0.02% 1063
2022
Q3
$993K Buy
95,876
+21,379
+29% +$242K 0.02% 1102
2022
Q2
$859K Buy
+74,497
New +$878K 0.01% 1188

Other funds holding IRWD

Texas Permanent School Fund's IRWD Position: Q2 2024 in Review

Texas Permanent School Fund sold out of Ironwood Pharmaceuticals (IRWD) in Q2 2024, closing a stake of 120,245 shares — an estimated $1.05M sold.

Texas Permanent School Fund first reported a position in IRWD in Q2 2022 and held it in 8 quarters. The position peaked at $1.36M in Q4 2023. 226 funds tracked by Wall St. Rank hold IRWD as of Q2 2024.

  • Texas Permanent School Fund reported no remaining Ironwood Pharmaceuticals position as of Q2 2024 after selling out during the quarter.
  • Texas Permanent School Fund sold 120,245 Ironwood Pharmaceuticals shares in Q2 2024, an estimated $1.05M.
  • Texas Permanent School Fund first reported a position in Ironwood Pharmaceuticals in Q2 2022 and held it in 8 quarters.
  • Texas Permanent School Fund's Ironwood Pharmaceuticals position peaked at $1.36M in Q4 2023.
  • 226 funds tracked by Wall St. Rank held Ironwood Pharmaceuticals as of Q2 2024.

Based on Texas Permanent School Fund's 13F filing for Q2 2024, filed 7 Aug 2024.